Gyre Therapeutics, Inc. (GYRE)

Last Closing Price: 9.46 (2025-05-29)

Earnings Announcements: Estimated vs Actual

On 2025-05-09, Gyre Therapeutics, Inc. (GYRE) announced earnings per share of $0.00 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $0.03.

The next expected annoucement date for quarterly earnings is 2025-08-12, with an average estimated earnings per share of $0.03 for the fiscal quarter ending 2025-06-30.

Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.

Announcement Date Fiscal Quarter End Estimated EPS Actual EPS
2025-05-09 2025-03-31 $0.03 $0.00
2025-03-17 2024-12-31 $0.04 $0.01
2024-11-13 2024-09-30 -- $0.02
2024-08-13 2024-06-30 -- $0.01
2024-05-09 2024-03-31 -- $0.04
2023-10-26 2023-09-30 $-0.75 $-0.60
2023-08-14 2023-06-30 $-1.05 $-1.05
2023-05-15 2023-03-31 -- $-1.65
2023-03-30 2022-12-31 -- $-19.19
2022-11-14 2022-09-30 -- $-2.40
2022-08-15 2022-06-30 $-3.30 $-2.70
2022-05-09 2022-03-31 $-8.40 $-6.90
2022-03-31 2021-12-31 $-8.10 $-9.60
2021-11-12 2021-09-30 $-9.90 $-11.99
2021-08-05 2021-06-30 $-10.19 $-9.60
2021-05-06 2021-03-31 $-11.54 $-11.84
2021-03-04 2020-12-31 $-13.34 $-12.89
2020-11-05 2020-09-30 $-14.24 $-10.94
2020-08-06 2020-06-30 $-15.74 $-14.39
2020-05-11 2020-03-31 -- $-4.20
2020-02-20 2019-12-31 $-18.44 $-18.44
2019-11-07 2019-09-30 $-17.84 $-15.89
2019-08-01 2019-06-30 $-17.99 $-17.24
2019-05-02 2019-03-31 $-13.04 $-18.89
2019-03-07 2018-12-31 $-11.09 $-13.64
2018-11-01 2018-09-30 $-8.55 $-9.60
2018-08-02 2018-06-30 $-8.85 $-8.10
2018-05-03 2018-03-31 $-19.49 $-8.40
2018-03-01 2017-12-31 $-21.14 $-14.39
2017-11-02 2017-09-30 -- $-20.09
2017-08-03 2017-06-30 -- $-37.93
2017-05-11 2017-03-31 $-105.70 $-68.52
2017-03-08 2016-12-31 $-105.70 $-70.16
2016-11-03 2016-09-30 $-107.89 $-89.91
2016-08-04 2016-06-30 $-69.68 $-94.41
2016-05-05 2016-03-31 -- $-69.68
2015-07-31 2015-06-30 -- $-157.30
2015-05-07 2015-03-31 -- $-314.59